B.N. Hoogeboom

Faculteit Medische Wetenschappen/UMCG

Telefoon:

E-mail:

b.n.hoogeboom umcg.nl

Research Portal

Publicaties

Effect of repurposed metabolic drugs on human macrophage polarization and antitumoral activity

Vizcaino-Castro, A., Chen, S., Hoogeboom, B. N., Boerma, A., Daemen, T. & Oyarce, C., mrt.-2025, In: Clinical Immunology. 272, 10 blz., 110440.

Onderzoeksoutput › › peer review

Programming alphavirus with IFN-γ overrides the adverse effects of macrophages on oncolytic virotherapy

Horváthová, L., Hoogeboom, B. N., Janzen, T., Weissing, F., Daemen, T. & Bhatt, D., 16-feb.-2025, BioRxiv, 26 blz.

Onderzoeksoutput: Voordruk ›

An in vitro CD8 T-cell priming assay enables epitope selection for hepatitis C virus vaccines

Koutsoumpli, G., Stasiukonyte, N., Hoogeboom, B. N. & Daemen, T., 17-sep.-2024, In: Vaccine. 42, 22, 10 blz., 126032.

Onderzoeksoutput › › peer review

Oncolytic alphavirus replicons mediated recruitment and activation of T cells

Bhatt, D. K., Meuleman, S. L., Hoogeboom, B. N. & Daemen, T., 15-mrt.-2024, In: Iscience. 27, 3, 16 blz., 109253.

Onderzoeksoutput › › peer review

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

Komdeur, F. L., Singh, A., van de Wall, S., Meulenberg, J. J. M., Boerma, A., Hoogeboom, B. N., Paijens, S. T., Oyarce, C., de Bruyn, M., Schuuring, E., Regts, J., Marra, R., Werner, N., Sluis, J., van der Zee, A. G. J., Wilschut, J. C., Allersma, D. P., van Zanten, C. J., Kosterink, J. G. W. & Jorritsma-Smit, A.& 3 anderen, Yigit, R., Nijman, H. W. & Daemen, T., 3-feb.-2021, In: Molecular Therapy. 29, 2, blz. 611-625 15 blz.

Onderzoeksoutput › › peer review

Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?

Koutsoumpli, G., Ip, P. P., Schepel, I., Hoogeboom, B. N., Boerma, A. & Daemen, T., 1-jan.-2019, In: Therapeutic Advances in Vaccines and Immunotherapy. 7, blz. 1-13 13 blz.

Onderzoeksoutput › › peer review

A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

Draghiciu, O., Boerma, A., Hoogeboom, B. N., Nijman, H. W. & Daemen, T., 2015, In: OncoImmunology. 4, 10, 9 blz., 1029699.

Onderzoeksoutput › › peer review

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

Draghiciu, O., Nijman, H. W., Hoogeboom, B. N., Meijerhof, T. & Daemen, T., mrt.-2015, In: OncoImmunology. 4, 3, 11 blz., 989764.

Onderzoeksoutput › › peer review

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

van de Wall, S., Walczak, M., van Rooij, N., Hoogeboom, B.-N., Meijerhof, T., Nijman, H. W. & Daemen, T., 24-mrt.-2015, In: Vaccines. 3, 2, blz. 221-238 18 blz.

Onderzoeksoutput › › peer review

Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination

Draghiciu, O., Walczak, M., Hoogeboom, B. N., Franken, K. L. M. C., Melief, K. J. M., Nijman, H. W. & Daemen, T., 15-feb.-2014, In: International Journal of Cancer. 134, 4, blz. 859-872 14 blz.

Onderzoeksoutput › › peer review

Alle (20) publicaties

Bekijk volledig onderzoeksprofiel